Phyllis Chan
-
- Cancer Immunotherapy and Biomarkers 12
- CAR-T cell therapy research 6
- Colorectal Cancer Treatments and Studies 5
- Pancreatic and Hepatic Oncology Research 4
-
- Hepatitis C virus research 6
- Statistics and Probability top 10%
-
- Attention Deficit Hyperactivity Disorder 4
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Biosimilars and Bioanalytical Methods 7
- Co-authors
- René BrunoEsther W. ChanPatrick IpIan Chi Kei WongBenjamin WuKenneth K. C. ManKirill PeskovXuyang Song
- Journals
- CPT Pharmacometrics & Systems Pharmacology (6 papers)Cancer Chemotherapy and Pharmacology (3 papers)The Journal of Clinical Pharmacology (3 papers)
- Partner nations
- United StatesFranceChina
In The Last Decade
Phyllis Chan
37 papers receiving 545 citations
Peers
Comparison fields: 5 of 86
- Oncology 161
- Hepatology 42
- Statistics and Probability 40
- Psychiatry and Mental health 72
- Gastroenterology 26
Countries citing papers authored by Phyllis Chan
This map shows the geographic impact of Phyllis Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis Chan more than expected).
Fields of papers citing papers by Phyllis Chan
This network shows the impact of papers produced by Phyllis Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis Chan. The network helps show where Phyllis Chan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Phyllis Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 23 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 24 | |
| 11 | 2021 | 24 | |
| 12 | 2021 | 16 | |
| 13 | 2020 | 14 | |
| 14 | 2020 | 12 | |
| 15 | 2018 | 4 | |
| 16 | 2017 | 91 | |
| 17 | 2017 | 23 | |
| 18 | 2017 | 11 | |
| 19 | 2016 | 2 | |
| 20 | 2015 | 31 |
About Phyllis Chan
Phyllis Chan is a scholar working on Hepatology, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Psychiatry and Mental health, having authored 38 papers that have together received 567 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Biosimilars and Bioanalytical Methods (7 papers), CAR-T cell therapy research (6 papers), Hepatitis C virus research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Attention Deficit Hyperactivity Disorder (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Oncology (161 citations), Hepatology (42 citations), Statistics and Probability (40 citations), Psychiatry and Mental health (72 citations) and Gastroenterology (26 citations). Phyllis Chan has collaborated with scholars based in United States, France and China. Frequent co-authors include René Bruno, Esther W. Chan, Patrick Ip, Ian Chi Kei Wong, Benjamin Wu, Kenneth K. C. Man, Kirill Peskov, Xuyang Song, Jin Y. Jin and Wallis C. Y. Lau. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, Cancer Chemotherapy and Pharmacology, The Journal of Clinical Pharmacology, BMC Psychiatry and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.